drugdiscoverynews.com


drugdiscoverynews.com Website Info

drugdiscoverynews.com (Drug Discovery News is a leading online platform providing news, analysis, and insights into the latest developments in drug discovery, pharmaceutical research, and biomedical innovations, serving professionals in the healthcare and biotech industries.) was registered first at 2004-09-22 16:40:33. It's hosted by GoDaddy.com, LLC. DNS looks Active and website looks Accessable. drugdiscoverynews.com Website SEMRush Rank is 676,985. According to Google, website speed score is 77/100 and FAST. Website looks safe for children. We detected the website language as en.
drugdiscoverynews.com


drugdiscoverynews.com Website Tags

Domain Status:
✓ Active
Is Site Accessable?:
✓ Yes
SSL(https):
✓ Yes
Title:
Drug Discovery News | Innovations & Insights in Pharmaceutical Research
Description:
DDN provides engaging stories about scientific breakthroughs to help life science researchers develop diagnostic and therapeutic approaches for improving human health.
Categories :
Health, Health and Wellness
External Links:
3
Internal Links:
85
Mobile Friendly?:
✓ Yes
Canonical URL:
https://www.drugdiscoverynews.com
Language:
en
XML Sitemap:
✓ Yes
robots.txt:
✓ Yes https://www.drugdiscoverynews.com/robots.txt
Favicon:
✗ No

drugdiscoverynews.com Domain & Whois Details

Refresh
Domain Create Date:
2004-09-22 16:40:33
Domain Age:
20 years, 9 months, 16 days
Domain Expire Date:
2023-09-22T16:40:33Z
Domain Last Update Date:
2023-09-22T16:40:33Z
Domain Owner:
http://www.godaddy.com - GoDaddy.com, LLC -
Server Software:
Express
Nameservers:
NS11.CONSTELLIX.COM - NS21.CONSTELLIX.COM - NS31.CONSTELLIX.COM - NS41.CONSTELLIX.NET - NS51.CONSTELLIX.NET - NS61.CONSTELLIX.NET -
Hosting Location:
Country:Canada, City:Mississauga, Isp:Internet Light and Power Inc, Org:LabX Media Group
Hosting Provider:
GoDaddy.com, LLC
IP:
216.223.155.117 , 216.223.155.116

drugdiscoverynews.com Backlinks & Rankings

SEMRush Rank:
676,985
Semrush Rank is a proprietary score that lets you find the domains that are getting the most traffic from organic search.
SEMRush Traffic:
1,405
Number of users expected to visit the website during the following month.
SEMRush Costs:
1,216
Estimated price of organic keywords in Google AdWords.
SEMRush URL Links:
531
Number of links to URL according to SemRush.
SEMRush Website Links:
302,022
Number of links to the website according to SemRush.
SEMRush Domain Links:
400,946
Number of links to SemRush Domain.
SEMRush Keywords In Top 100:
10,006
Number of keywords where site in Google's organic search top 100.

drugdiscoverynews.com Social Media

Facebook Comments:
1
Facebook Shares:
477
Facebook Reactions:
12

drugdiscoverynews.com Website Speed (Desktop)

Refresh
Overall Category:
FAST
The human readable speed "category"
Speed Index:
77
Speed Index shows how quickly the contents of a page are visibly populated. [Learn more about the Speed Index metric].
Cumulative Layout Shift (CLS):
0.09 (FAST)
The Cumulative Layout Shift (CLS) metric measures how much unexpected layout shifts affect the user experience on a page. These layout shifts occur when content moves around without prior user input. CLS
Time to First Byte (TTFB):
0.417 s (FAST)
TTFB (time to first byte) is the number of milliseconds it takes for a client’s browser to receive the first byte of the response from the web server. Usually, TTFB can be improved with faster hosting and server optimizations. TTFB
First Input Delay (FID):
3 ms (FAST)
First Input Delay (FID) measures the time from when the user interacts with your site for the first time (click a link, tap on a button, etc.) to the time when the browser is able to respond to that interaction. Google recommends keeping FID below 100ms for a good user experience. FID
First Contentful Paint (FCP):
0.873 s (FAST)
FCP (First Contentful Paint) measures the time from a user’s navigation to when the browser renders the first bit of content from the DOM. In other words, FCP marks the time at which the first text or image is painted for the user. According to PageSpeed Insights, FCP should occur in under 2 seconds. FCP
Interaction to Next Paint (INP):
38 ms (FAST)
Interaction to Next Paint (INP) is a web performance metric that measures user interface responsiveness – how quickly a website responds to user interactions like clicks or key presses. Specifically, it measures how much time elapses between a user interaction like a click or key press and the next time the user sees a visual update on the page. INP
Largest Contentful Paint (LCP):
1.242 s (FAST)
Largest Contentful Paint (LCP) is a metric that measures when the largest content in the viewport is rendered. It is used to measure how long it takes for the main content of your webpage to appear on the screen. Everything below 2.5s is considered good LCP time by PageSpeed Insights. LCP
Total Size:
2794 KB
Total Size. Large network payloads cost users real money and are highly correlated with long load times.
Server Response Time:
229 ms
Initial server response time. Keep the server response time for the main document short because all other requests depend on it. [Learn more about the Time to First Byte metric](https://developer.chrome.com/docs/lighthouse/performance/time-to-first-byte/).
Final Url:
https://www.drugdiscoverynews.com/
Canonicalized and final URL for the document, after following page redirects (if any).
Last Date Checked:
5/30/2023 4:37:08 PM
The last time we checked this website.

drugdiscoverynews.com HTML Resources

Type
Request Count
Size
Total
126
2,794 KB
Third-party
108
2,376 KB
Image
41
1,300 KB
Script
36
1,267 KB
Other
40
116 KB
Font
4
49 KB
Stylesheet
1
42 KB
Document
4
18 KB
Media
0
0 KB

drugdiscoverynews.com Website Safety

Refresh
Last Check Date:
3/3/2023 1:00:12 AM
Fortiguard:
Health and Wellness
Mcafee Category:
Health
OpenDNS:
notdecidedyet
Cloudflare DNS:
OK
MyWot Child Safety:
99

drugdiscoverynews.com HTTP Headers

Refresh
access-control-allow-headers :
Content-Type, Authorization
access-control-allow-methods :
GET
Access-Control-Allow-Origin :
undefined
Connection :
close
Content-Length :
41271
Content-Type :
text/html; charset=utf-8
Date :
Sat, 13 May 2023 02:48:40 GMT
ETag :
W/"a137-Y0Go75uMXWglwcLQGDe9NTr80ak"
Set-Cookie :
remember=true; Path=/; Secure
Vary :
Accept-Encoding
x-content-type-options :
nosniff
X-Frame-Options :
SAMEORIGIN
X-Powered-By :
Express
x-xss-protection :
1;mode=block


drugdiscoverynews.com W3C HTML Validation Check Now

Last Check Date:
5/27/2023 12:00:00 AM
Errors:
91
Warnings:
0
Info:
8

drugdiscoverynews.com Similar Sites

Website
Title
Rank
WuXi AppTec | Leading Global Pharma and Biotech CDMO Provider
139,739
BiotechnologyJobs.com | Biotechnology, Pharmaceutical, Medical Device & Diagnostics Recruitment Specialists
42,955,168
CEM.com - Leading Material Testing and Certification Services
353,731
Life Science Exhibits
World Pharma News - Latest Updates in the Pharmaceutical Industry
4,617,177

drugdiscoverynews.com Site Keywords

biomedical innovation
biotech
chemical and engineering news
chemical-engineering news
DDN Magazine
development
Diagnostics Articles
discovery
drug development
Drug Discovery
Drug Discovery News
Health News
life sciences
modern drug discovery
pharma development
Pharmaceutical development
pharmaceutical discovery
pharmaceutical research

drugdiscoverynews.com Site H Tags

Check Now
h2
News
h2
How to grow an ear and why
h2
The bumpy road to treating multiple sclerosis with stem cells
h2
The bumpy road to treating multiple sclerosis with stem cells
h2
A living antibiotic: Bdellovibrio bacteria attack and destroy human pathogens
h2
An in utero stem cell transplant for alpha thalassemia
h2
Resources
h2
Tools & Techniques
h2
Disease Focus
h3
The intricate design of a fundamental filter protein
h3
The intricate design of a fundamental filter protein
h3
Immunologists hack body rhythms for medicine
h3
Immunologists hack body rhythms for medicine
h3
Taming the immune response to gluten to treat celiac disease
h3
Taming the immune response to gluten to treat celiac disease
h3
New genetic pathways involved in aging
h3
New genetic pathways involved in aging
h3
Targeting nutrient signaling in the gut to tackle metabolic disease
h3
Targeting nutrient signaling in the gut to tackle metabolic disease
h3
Aging dogs provide insights for human longevity
h3
Aging dogs provide insights for human longevity
h6
A collaboration of nephrologists and biochemists created the first structure of “megalin,” a critica
h6
Biogerontologist Matt Kaeberlein studies aging pets to determine how to improve healthspan in dogs a
h6
A new oral bead technology is designed to stimulate nutrient-sensing cells in discrete parts of the
h6
Researchers develop gluten-degrading enzymes to administer as drugs or incorporate into food and exp
h6
The success of vaccines and cancer treatments varies depending on the time of day they are delivered
h6
By analyzing the changing genomes of short- and long-lived rockfish, scientists identified a new set

drugdiscoverynews.com Sites with Same Names

Website
Title
Rank
Drug Discovery News

What is SitesDB?

SitesDB is one of the largest databases of websites and domain names on the internet, with over 40 million entries and growing. For more than 12 years, we've been manually verifying and updating website and domain details, combining human expertise with AI-powered systems to ensure the accuracy and relevance of our data.

At SitesDB, we provide in-depth technical and useful information about websites and domains, including:

  • Website meta tags
  • Domain & WHOIS data
  • General backlink and ranking statistics
  • Social media engagement stats
  • Root page speed insights
  • Website content and HTML resources
  • Website safety and security details, sourced from multiple trusted security providers
  • HTTP headers analysis
  • HTML validation reports
  • Lists of similar websites and competitors
  • Website keyword analysis, including top traffic-driving keywords
  • Heading structure (H tags) breakdown
  • Domain variations across different TLDs (Top-Level Domains)

In addition to this data, SitesDB offers a suite of website analysis tools — including Chrome CRUX, Google Lighthouse, and our own AI-enhanced algorithms — to help identify alternative websites, direct competitors, and similar sites, all continuously refined through both automated systems and human review.